Skip to main navigation Skip to search Skip to main content

CONTROLLED TRIAL OF SIMVASTATIN AND LOSARTAN IN PATIENTS WITH UNREMITTING NEPHROTIC SYNDROME

Project: Research

Project Details

StatusFinished
Effective start/end date05/1/9804/30/01

Funding

  • Merck Genome Research Institute: $28,300.00